1 / 82

The Management of Snoring and Obstructive Sleep Apnea Rex Moulton-Barrett, MD

The Management of Snoring and Obstructive Sleep Apnea Rex Moulton-Barrett, MD. Plastic and Reconstructive Surgery Otolaryngology & Head and Head Surgery Alameda Hospital June 2005. Spectrum of Sleep Disordered Breathing. Definitions U pper A irway R esistance S yndrome ( UARS ).

cicely
Télécharger la présentation

The Management of Snoring and Obstructive Sleep Apnea Rex Moulton-Barrett, MD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The Management of Snoring and Obstructive Sleep ApneaRex Moulton-Barrett, MD Plastic and Reconstructive Surgery Otolaryngology & Head and Head Surgery Alameda Hospital June 2005

  2. Spectrum of Sleep Disordered Breathing

  3. DefinitionsUpper Airway Resistance Syndrome ( UARS ) • • Daytime somnolence • • No significant apnea or O2 desaturation • • Habitual loud snoring (crescendo) • • they wake from their own noise of snoring • Guillaminault C, Stoohs R, Duncan S. Chest 99:40-48;1991 • Guilleminault C, Stoohs R, Clerk A et al. Chest 104:781-787;1993

  4. Definitions • Hypopnoea: ‘ Chicago Criteria’ 1. Fall in average tidal volume by > 50% but < 10 second apnoea or < 50% tidal volume reduction and 2. at least 4% in oxyhemoglobin desaturation 3. EEG evidence of arousal

  5. Definitions • Apnea • Cessation of airflow for at least 10 seconds • Obstructive / Central / Mixed • based on presence or absence of respiratory movement

  6. Prevalence of Sleep Apnea • AHI = RDI • = apnoea+hyponoea / hour • >5 : 24% Males & 9% Females • 4 - 6 times more common in men • 20 million Americans • Young T, Palta M, Dempsey J. N Engl J Med 328:1230-1235;1993

  7. Pathophysiology Scale • RDI / AHI • UARS <5 • Mild 5-20 • Moderate 21-40 • Severe >40

  8. A RDI of 15-20 events per hour is close to what adults seem to be able to tolerate with no clinical consequence. Hosselet JJ, Ayappa I, Norman RG et al. Classificatin of sleep-disordered breathing. Am J Respir Crit Care Med 163:398-405;2001 What is Significant RDI?

  9. 10x > risk, VAMV UCLA 2000

  10. Somnolence Induced MVAs 3 fold increase in motor vehicle accidents if RDI> 5

  11. Morbidity and Mortality • Risk factor for cardiovascular disease • Hypertension • MI –polycythemia, platelet aggregation • Stroke • Mortality • AI>20 = 37% mortality over 8 yrs compared with 4% for AI<20 (Chest 94:9-14, 1988)

  12. History • Heroic snoring • Cardinal symptom of OSAS • Observed apneas or choking • Excessive sleepiness • Witnessed apnoeas • Change in personality – depression, anxiety • Cognitive dysfunction – memory, concentration • Morning headaches • Decreased libido or impotence • Car or work accidents • History alone is only 60% specific and 60% sensitive • Need objective testing

  13. Sleep Apnea Risk Factors • •Obesity • •Increasing age • •Male gender • •Anatomical abnormalities of upper airway • •Family history • •Alcohol or sedative use • •Smoking

  14. Diagnosis: Physical Exam • Upper body obesity / thick neck • >17” males • >16” females • Airway abnormality • Nasal • Oropharyngeal • Hypopharyngeal

  15. Differential Diagnosis of OSAS • • Narcolepsy • REM sleep within 10 minutes • • Excessive daytime sleepiness associated with psychosocial and psychiatric disorders • • Drug related syndromes • • Restless Legs / Periodic limb movement disorder • • Idiopathic hypersomnolence

  16. Evaluation of Upper Airway • No consistent characteristic in OSA • Quantitative measures depend on state • Methods of Evaluation • Cephalometric radiographs

  17. Anatomic Factors in Airway Obstruction • •Increased nasal resistance. • •Excessive palatal length. • •Increased tongue size. • •Increased vertical airway length • •Enlarged tonsils. • •Mandibular retrusion.

  18. Impact of nose on snoring and OSAS • • Obstruction increases airway resistance • • Anterior rhinomanometric volume has an inverse relationship with RDI p<0.05 • • Nasal obstruction is an important cause of OSA • Virkkula, P et al. Acta Otolaryngol, 2003 • (Finland)

  19. Malampatti I-IV: Airway Classification Visualize • I:Soft palate, tonsils, uvula • II:No tonsils seen • III:Soft palate only seen • IV:Hard palate only seen IV

  20. Muller Maneuver Maximal inspiratory movement

  21. Velopharyngeal Closure Patterns • A. Coronal 71% • B. Circular 19% • C. Circular +Passavant’s Ridge 7% • D. Sagittal 2% • Finkelstein , Talmi , Nachman .Plastic Rec Surg 1992;89:631-639

  22. Snoring: “a marker for airway resistance during sleep” Hofffstein V, Mateika S, Nash S. Comparing Perceptions and Measurements of Snoring. Sleep 19:783-789;1996

  23. Balance of forces affecting airway Kuna ST, Sant’Ambrogio G. JAMA 266:1384-88;1991

  24. Pathophysiology of OSAS • • Collapse of pharyngeal airway • • Increased upper airway resistance • • Diaphragm movement increases negative airway pressure • • Increased airway collapse • • Hypopnea and apnea – increase vagal tone • • Hypoxia, Hypercarbia – catacholamine rise • • Increased ventilatory effort • • Sleep fragmentation and arousal

  25. Who to order a Sleep Study On ?

  26. Epworth v. RDI • RDIEPWORTH • 0 8.0+/-3.5 • Mild 12.1 11.0+/-4.2 • Mod 34.8 13.0+/-4.7 • Severe 56.6 16.2+/-3.3 T. Woodson - Monograph

  27. Why Get a Sleep Study ? • Documentation • Quantification • Determine Therapy

  28. Polysomnography • • Establish diagnosis of sleep apnea • • Assess disease severity • • Rule out other disorders of sleep • • CPAP titration • • Components: • EEG • EOG • EMG • EKG • Chest wall and abdominal wall impedance • Intercostal EMG • Body position • Pulse Oximetry

  29. In-Laboratory Polysomnography • Pros • “Full” set of variables recorded • Technician for patient & equipment problems • Able to determine success of C-Pap • Cons • Cost • Accessibility • Patient sleeps away from home • Fails to localize site of obstruction

  30. “The Polysomnographic Age …. has ended” • Unattended ambulatory monitoring is “biologically plausible and technologically feasible” • Strohl KP. When, Where and How to Test for Sleep apnea. Sleep 2000;23:S99-S101

  31. SNAP Testing • • PSG: polysomnograpghy “considered gold standard” • inherant variability, • problems of reproducibility • • SNAP testing: out-patient, localizes site of obstruction, inexpensive • • Direct and solid correlation between both for measurement of RDI • • For RDI >= 5 : 95% positive predictive value, • 96% specificity • 75% sensitivity • Allan, P, Chaney, J, Mair, E. Otolaryngol HNSurg, 2004

  32. SNAPTestingAcoustic Analysis ofOro-Nasal Respiration • • Sound & Airflow Detection • • Pulse Oximetry & Pulse rate • • Apnea & Hypopnea Indices • • Snoring Analysis • • 6 hours+ continuous recording

  33. SNAP Data Collection Cannula

  34. Effort & Movement Transducer

  35. Why SNAP ? • Patient Selection • OSA detection • Snoring Localization & Quantification • Outcome Monitoring

  36. SNAP - Apnea

  37. SNAP - Oximetry

  38. SNAP - Snoring

  39. OSA in Children • History • Shyness • Developmental Delay • Aggressive Behavior • Symptoms of ADD • Witnessed apneas: positive predictive value of 86% • T&A are usual source of obstruction • Several studies show improvement in behavior and school performance after T+A

  40. Treatment for OSA • Medical • Reduction of Risk factors • CPAP - Most common treatment • Drugs • Airway appliances • Surgical

  41. Reduction of Risk Factors • Obesity • Sleep hygiene • Nasal obstruction • Body position • Sedative and alcohol use

  42. Drugs • Oxygen - most widely used • Protriptyline • Theophyline • Progesterone • Nicotine • Serotonin antagonists • Modafinil (Provigil)

  43. Pharmacologic Treatment Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patientsby Arnulf I, Homeyer P, Garma L, Whitelaw WA, Derenne JP.Service de Pneumologie et Laboratoire du Sommeil,Hopital Pitie-Salpetriere, Paris, France. Respiration 1997; 64(2):159-61 ABSTRACT We studied the effects of modafinil, a vigilance-enhancing drug, on excessive daytime sleepiness, memory, night sleep and respiration in 6 patients with obstructive sleep apnea-hypopnea syndrome (OSAHS) using a double-blind random cross-over design with 24-hour polysomnography, verbal memory test and a 5-week sleep-wake diary kept by the patients. There were two 2-week treatment periods in which either modafinil or placebo was used; they were separated by a 1-week wash-out period. Our results show that modafinil reduces daytime sleep duration, lengthens the duration of subjective daytime vigilance and improves long-term memory in patients with OSAHS without modifying night sleep and respiration events.

  44. CPAP Splints the Upper Airway Collapsing forces • Tissue pressure and mass • Constrictor muscle tone • Negative inspiratory pressure Dilating forces • Dilating muscle tone • Tissue pressures that stabilize the airway • CPAP augments dilating forces

  45. CPAP Has Poor Compliance • CPAP is effective • Not a cure • Pattern of use established early • Drop out rate > 25% • 50% effective use

More Related